Establishment of a Tumor Bank for Blood Samples

Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ovarian Neoplasms Adnexal Diseases Breast Diseases Breast Neoplasms Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Intestinal Diseases Intestinal Neoplasms Lung Diseases Lung Neoplasms Neoplasm Metastasis Neoplasms Neoplasms by Site Neoplasms of the Female Genitalia Neoplastic Cells, Circulating Neoplastic Processes Ovarian Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Rectal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Innsbruck Medical University, Innsbruck, Austria

About this study

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient.

Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a tissue bank - see EK 260/2003) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male/Female
Age 18 to 90 years max.
Just one current known malignant disease or
Just one current inflammatory disease

Exclusion criteria

Inflammatory disease and malignant disease
multiple malignancies
multiple diseases
underage

Treatment and study plan

Blood collection

Other

Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.

Primary outcomes

Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls.

Time frame: 14 years

Study contacts

Contact information is provided by the study sponsor or research team.

Eva Obermayr, PhD

CONTACT

[email protected]

+43140400 ext. 78270

Robert Zeillinger, Prof. Dr.

CONTACT

[email protected]

+43140400 ext. 78310

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.

Important dates

Study start: 2003
Primary completion: 2026
Study completion: 2026
First posted: Jan 8, 2013
Registry last updated: Mar 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting